Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 9-MTH group results

Feb 7 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              200.05              214.30           269.00    
                   (-6.6 pct)          (+1.4 pct)       (-4.6 pct)  
  Operating            7.13               20.86            11.00    
                   (-65.8 pct)         (+22.1 pct)      (-44.9 pct) 
  Recurring           11.49               24.74            15.50    
                   (-53.5 pct)         (+22.0 pct)      (-40.3 pct) 
  Net                  8.97               14.24            11.50    
                   (-37.0 pct)         (-20.0 pct)      (-13.6 pct) 
  EPS              110.43 yen          178.35 yen       141.20 yen  
  EPS Diluted      110.30 yen          178.12 yen                   
  Ann Div                              100.00 yen       100.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               50.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news